255 related articles for article (PubMed ID: 12561434)
1. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
Cheng LM; Wang SY; Lin JS
Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
[TBL] [Abstract][Full Text] [Related]
2. [PTEN expression and its significance in human primary hepatocellular carcinoma].
Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
4. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer.
Dong-Dong L; Xi-Ran Z; Xiang-Rong C
J Cell Mol Med; 2003; 7(1):67-71. PubMed ID: 12767263
[TBL] [Abstract][Full Text] [Related]
6. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the expression of PTEN protein and phosphorylation of MAPK in hepatocellular carcinomas and their surrounding liver tissues].
Feng DY; Cheng RX; Zheng H
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):117-20. PubMed ID: 12575334
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
Chung TW; Lee YC; Ko JH; Kim CH
Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
[TBL] [Abstract][Full Text] [Related]
10. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
Wan XW; Jiang M; Cao HF; He YQ; Liu SQ; Qiu XH; Wu MC; Wang HY
J Cancer Res Clin Oncol; 2003 Feb; 129(2):100-6. PubMed ID: 12669234
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors.
Mawrin C; Kirches E; Boltze C; Dietzmann K; Roessner A; Schneider-Stock R
Virchows Arch; 2002 Jun; 440(6):610-5. PubMed ID: 12070601
[TBL] [Abstract][Full Text] [Related]
13. PTEN/MMAC1 mutations in hepatocellular carcinomas.
Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
[TBL] [Abstract][Full Text] [Related]
15. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
Hsia CC; Nakashima Y; Thorgeirsson SS; Harris CC; Minemura M; Momosaki S; Wang NJ; Tabor E
Oncol Rep; 2000; 7(2):353-6. PubMed ID: 10671685
[TBL] [Abstract][Full Text] [Related]
16. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
Caruso ML; Valentini AM
Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
[TBL] [Abstract][Full Text] [Related]
18. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
[TBL] [Abstract][Full Text] [Related]
19. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
20. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]